Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like 1-Year Old Biotech Goldfinch Steals AstraZeneca R&D Exec for CEO Post December 5, 2017 <b>Dynamk Capital</b> Announces First Closing And Launch Of Life Sciences Venture Fund September 25, 2017 Bristol-Myers Who? Why a Marriage Between Pfizer and Biogen Makes More Sense November 13, 2017
<b>Dynamk Capital</b> Announces First Closing And Launch Of Life Sciences Venture Fund September 25, 2017
